Cenra Inc
TTWSE:371633.65
TWD
0.00
(0.00%)
ISIN
TW0003716007
Return %
Stock
S&P 500
1Y
-1.75
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
TWD
•
in mil. unless spec.Working Capital
TWD
•
in mil. unless spec.Growth Rates
TWD
•
in mil. unless spec.Quarterly Revenue
TWD
•
in mil. unless spec.Quarterly Earnings Per Share
TWD
•
in mil. unless spec.Quarterly Dividends Per Share
TWD
•
in mil. unless spec.Company Description
- CEO
- Chih Yung Wu
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Taipei Taiwan
- IPO Date
- Sep 2, 2024
- Website
- ccpc.com.tw
- Similar Companies
- Business
- Cenra Inc., through its subsidiaries, operates as an integrated healthcare and pharmaceutical holding company primarily in Taiwan, the wider Asia-Pacific region, North America, and Europe. The company researches, develops, manufactures, markets, and distributes human pharmaceuticals, active pharmaceutical ingredients (APIs), animal health solutions, consumer health products, and provides eldercare and contract development and manufacturing organization (CDMO) services. The company operates through five principal business segments: Human Pharmaceuticals, Active Pharmaceutical Ingredients, Healthcare and Distribution, Animal Health, and Senior Care Services. Its Human Pharmaceuticals segment develops and manufactures a broad portfolio of generic prescription drugs and specialty formulations across therapeutic areas including cardiovascular diseases, central nervous system disorders, metabolic and endocrine conditions, gastrointestinal disorders, infectious diseases, respiratory conditions, and dermatological ailments; dosage forms include solid oral tablets and capsules, extended-release formulations, sterile injectables, oral suspensions, ophthalmic solutions, and topical ointments and creams. Its Active Pharmaceutical Ingredients segment, operated through Cenra API Solutions (Chunghwa Chemical Synthesis and Biotech Co., Ltd.), synthesizes, manufactures, and exports synthetic and fermentation-derived APIs, biotech products, immunosuppressants, and advanced chemical intermediates to global regulated markets. The Healthcare and Distribution segment, managed through Cenra Healthcare (China Chemical Yumin Healthcare Co., Ltd.), provides commercial distribution, regulatory affairs, marketing, and supply chain logistics for ethical prescription drugs, over-the-counter (OTC) medications, nutritional supplements, vitamins, medical devices, and personal skincare products. The Animal Health segment manufactures and distributes veterinary therapeutics, vaccines, nutritional additives, and healthcare formulations for livestock and companion animals. Its Senior Care Services segment, operated through Cenra Senior Care, provides institutional eldercare consulting, day care operations, in-home healthcare services, and professional caregiver training programs. In addition, Cenra Inc. provides end-to-end CDMO and CMO services, encompassing formulation development, pilot batch scale-up, analytical method validation, and commercial-scale cGMP manufacturing. In September 2024, the group completed a comprehensive corporate reorganization through a share exchange to establish Cenra Inc. as its public holding company, resulting in the listing of Cenra Inc. on the Taiwan Stock Exchange under ticker 3716 and the transition of China Chemical and Pharmaceutical Co., Ltd. into a wholly owned operating subsidiary. Alongside this structural transition, the company unified and rebranded its operational business units under the Cenra corporate identity to enhance strategic resource allocation and accelerate international commercialization. In recent strategic developments, the group expanded its commercial healthcare alliance portfolio, including co-promotion and distribution agreements with global biopharmaceutical companies such as Moderna for mRNA respiratory vaccines in Taiwan, while continuously investing in the modernization and regulatory compliance of its PIC/S GMP-certified manufacturing infrastructure to drive contract manufacturing expansion across North America and Asia. Cenra Inc. traces its corporate origins to the founding of China Chemical and Pharmaceutical Co., Ltd. in 1952 and is headquartered in Taipei, Taiwan.